| GlaxoSmithKline AG - Wellvone, Suspension | | 53563 | | 01 | | Wellvone | | Suspension | | P01AX06 | | Atovaquon | | 29.05.1996 | | |
| | Composition | | atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml. | | Packungsbestandteile | | Suspension | | | | | | | | Principe actif | Concentr. |
|---|
| Atovaquone | 750mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Atovaquone | 750 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acetaldehydum | | | Alcohol Benzylicus | 0.66mg / 5ml | | Amylis Acetas | | | Aqua Purificata | | | Aromatica (Vielfrucht) cum Aurantii Dulcis Aetheroleum | | | Aurantii Dulcis Aetheroleum Concentratum | | | Ethylis Butyras | | | Poloxamer | 188 | | Propylenglycol | | | Saccharinum Natricum | | | Vanilline | | | Xanthani Gummi | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 015 | 210 ml | 432.15 | 486.40 | A | LS | Oui |
|
|
